Physician profile
Ross Sage
NPI 1417253428
$913.45
in general payments reported to CMS, 2019-2025
11 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.07 · 2020: $166 · 2021: $91.99 · 2022: $384 · 2023: $89.76 · 2024: $19.07 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.58 | 2020-2025 | Skyrizi |
| Fujifilm Healthcare Americas Corporation | $199.16 | 2022 | |
| Genzyme Corporation | $153.76 | 2022-2025 | |
| Janssen Biotech, INC. | $103.67 | 2021-2022 | |
| Braintree Laboratories, INC. | $30.09 | 2021-2022 | |
| Boston Scientific Corporation | $22.07 | 2019 | |
| Medtronic, INC. | $20.32 | 2021 | |
| Celgene Corporation | $20.14 | 2022 | |
| Eisai INC. | $14.96 | 2021 | |
| Alfasigma USA, INC. | $14.94 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Sage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.